Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trenton News Today.
Press releases published on July 7, 2025
Antoine Turzi, President of RegenLab USA, Drives Innovation Forward with Grand Opening of Flagship U.S. Facility
EIN Presswire
·
July 7, 2025
Antoine Turzi opens RegenLab USA’s flagship facility in Jersey City, unveiling U.S.-made innovations in regenerative medicine and debuting the new Regen4D line. JERSEY CITY, NJ, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Antoine Turzi has …
Princeton Seminary Hosts 2025 Black Theology & Leadership Institute: Reimagining the Black Church’s Prophetic Potential
EIN Presswire
·
July 7, 2025
A transformational week of theological reflection, spiritual renewal, and leadership development for Black church leaders, scholars, …
Aterian Announces Exclusive Prime Day Deals Across Six Leading Brands
GlobeNewswire
·
July 7, 2025
SUMMIT, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today unveiled its Prime Day lineup offering limited-time deals of up to 36% off top-rated products across six of its premier e-commerce brands— …
Epoxy Resin Market is expected to generate a revenue of USD 21.37 Billion by 2032, Globally, at 5.9% CAGR: Verified Market Research®
GlobeNewswire
·
July 7, 2025
Lewes, Delaware, July 07, 2025 (GLOBE NEWSWIRE) -- The Global Epoxy Resin Market Size is projected to grow at a CAGR of 5.9% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was valued …
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
GlobeNewswire
·
July 7, 2025
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a significant extension of the product range, …
CompoSecure Wins Four Prestigious ICMA Élan Awards for its Innovative Card Design
GlobeNewswire
·
July 7, 2025
SOMERSET, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced it was a winner of the prestigious 2025 Élan Award of Excellence by the …
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 7, 2025
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
GlobeNewswire
·
July 7, 2025
WARREN, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure
GlobeNewswire
·
July 7, 2025
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated an overall response rate (ORR) of 23% and a disease control rate (DCR) of 54% in non-irradiated lesions. Biomarker …
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER
GlobeNewswire
·
July 7, 2025
- Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults - KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: …
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
GlobeNewswire
·
July 7, 2025
Kuala Lumpur, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it has entered into an …